Allergan Rejects Valeant’s $47 Billion Bid as Shire Buys Lumena

13.05.2014 - U.S. drugmaker Allergan has rejected the $47 billion takeover bid of Canada-based Valeant Pharmaceuticals International, saying the suitor's proposed cost cuts of at least $2.7...